Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation (Q40593443)
Jump to navigation
Jump to search
scientific article published on January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation |
scientific article published on January 2004 |
Statements
1 reference
Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation (English)
1 reference
Daniela Matei
1 reference
David D Chang
1 reference
Meei-Huey Jeng
1 reference
1 January 2004
1 reference
1 reference
10
1 reference
2
1 reference
681-690
1 reference
1 reference
Identifiers
1 reference
1 reference